Skip to content

Clinical trials

Pregnancy Complications trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pregnancy Complications Country / region: France Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20101
20111
20121
20141
20152
20162
20171
20192
20201
20211
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Lille4
Assistance Publique - Hôpitaux de Paris3
Central Hospital, Nancy, France2
Centre Hospitalier Universitaire de Besancon2
Centre Hospitalier Universitaire de Nīmes2
Centre Hospitalier Intercommunal Creteil1
Centre Hospitalier Universitaire Dijon1
Centre Hospitalier Universitaire, Amiens1
Centre Médical Porte Verte1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pregnancy Complications20
Obesity3
Pre-Eclampsia3
Obstetric Labor, Premature2
Anxiety Disorders1
COVID-191
Central Nervous System Infections1
Communicable Diseases1
Depression, Postpartum1
Depressive Disorder1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.